Ozone Laboratories entered the Romanian pharmaceutical market in 2001.  Our outstanding success in Romania provided us with the necessary experience and resources to expand our business model at a Regional level, within Central & Eastern Europe. 

In 2004, we launched an investment program to expand our product portofolio by upgrading local partners' production facilities and by registering new products on the Romanian and five other Central and Eastern European markets.

In September 2006, Ozone Laboratories signed a regional partnership with Bristol Myers Squibb to market and sell the American company's products in Poland, Bulgaria and Slovakia.  This partnership strengthened our position within the Region and highlighted our reputation as a reliable partner.  Plans are in place to further strengthen our position by forming similar local and regional alliances.

By the end of 2007, Ozone Laboratories grew to EUR 61.5 million turnover through our strong presence in the following countries:  Bulgaria, Czech Republic, Hungary, Poland, Romania and Slovakia.  

Our deomonstrable track record of organic growth, our strong product pipeline and our well established infrastructure has placed us in an excellent postion for the next stage of our development.

Click on the desired country to view the corresponding Ozone website: